Heron Therapeutics reported $32.96M in Selling and Administration Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
ALKERMES ALKS:US 145.05M 15.36M
Alnylam Pharmaceuticals ALNY:US $ 154.47M 31.91M
Amarin AMRN:US 90.65M 1.72M
Ani Pharmaceuticals ANIP:US $ 28.82M 1.89M
Anika Therapeutics ANIK:US $ 19.2M 1.23M
Arrowhead Research ARWR:US $ 33.86M 9.27M
Eisai 4523:JP 110.49B 9.03B
Emergent Biosolutions EBS:US $ 84.8M 9.4M
Endo International Ordinary Shares ENDP:US 226M 18.48M
Esperion Therapeutics ESPR:US $ 30.38M 5.29M
GlaxoSmithKline GSK:LN 2.68B 227M
Heron Therapeutics HRTX:US $ 32.96M 1.42M
Immunogen IMGN:US $ 16.65M 3.07M
Insmed INSM:US $ 56.75M 8.52M
JAZZ PHA JAZZ:US 308.81M 53.95M
Ligand Pharmaceuticals LGND:US $ 18.18M 444K
Merk MRK:US $ 2.3B 518M
Nektar Therapeutics NKTR:US $ 27.34M 4.8M
Pacira Pharmaceuticals PCRX:US $ 64.26M 13.06M
Regeneron Pharmaceuticals REGN:US $ 450M 109.6M
Sangamo Biosciences SGMO:US $ 14.91M 1.18M
Surmodics SRDX:US $ 11.11M 1.92M
Teva Pharmaceutical Industries TEVA:US 819M 39M
Ultragenyx Pharmaceutical RARE:US $ 67.31M 7.88M
Veracyte VCYT:US $ 44.14M 15.82M
Vertex Pharmaceuticals VRTX:US $ 215.2M 39.96M